CLOVER-2 Phase 1 Clinical Study Evaluating Iopofosine I 131 in Relapsed/Refractory Pediatric High-Grade Glioma Patients Showed Extended Progression-Free Survival and Overall SurvivalFLORHAM PARK, N.J., Sept. 30, 2025 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery and development of drugs for the treatment of cancer, today announced that Jarrod Longcor, chief operating officer of Cellectar, delivered an oral presentatio ...

Nearly 1 million digital cards delivered represents record volume for the company; proprietary automation and strategic partnerships drive industry-leading fulfillment speed SCHAUMBURG, IL, Sept. 30, 2025 (GLOBE NEWSWIRE) -- Giftify, Inc. (NASDAQ: GIFT) (the "Company"), the owner and operator of CardCash.com, Restaurant.com, and Takeout7.com, and a leader in the incentives and rewards industry, today CardCash.com (“CardCash”) achieved record performance over the past year, delivering nearly $150 million in ...

Disc is seeking accelerated approval and priority review of its NDA submissionFDA decision to accept and file the NDA for review occurs within 60 days of submission WATERTOWN, Mass., Sept. 30, 2025 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases, today announced the submission of a New Drug Application (NDA) to the U.S. Fo ...

NEW YORK, Sept. 30, 2025 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS” or the “Company”), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for a broad range of cancer indications, today announced that it will host a virtual R&D Day on Wednesday, October 29, 2025 at 10:00 AM ET featuring key opinion leaders (KOLs), alongside company management, to discuss the unmet medical need and evolving treatment landscape for acute myeloid leuke ...

ESCONDIDO, Calif., Sept. 30, 2025 (GLOBE NEWSWIRE) -- One Stop Systems, Inc. (“OSS” or the “Company”) (Nasdaq: OSS), a leader in rugged Enterprise Class compute for artificial intelligence (AI), machine learning (ML) and sensor processing at the edge, today announced that it has entered into securities purchase agreements with certain new and existing institutional investors for the purchase and sale of 2,500,000 shares of common stock at a purchase price of $5.00 per share, pursuant to a registered direct ...

VANCOUVER, British Columbia, Sept. 30, 2025 (GLOBE NEWSWIRE) -- ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) ("ZenaTech"), a business technology solution provider specializing in AI (Artificial Intelligence) drones, Drone as a Service (DaaS), Enterprise SaaS, and Quantum Computing solutions, today announces that it is building a proprietary quantum computing hardware platform to power ZenaDrone’s AI drones for real time immense data applications and predictions. The platform will be applied to defen ...

Partners drive participation for GPSS Apex League for immersive sim racing experiencesSINGAPORE, Sept. 30, 2025 (GLOBE NEWSWIRE) -- Trident Digital Tech Pte Ltd (“Trident” or the “Company,” NASDAQ: TDTH); a leading catalyst for digital transformation in technology optimization services and Web 3.0 activation based in Singapore; and, OutDrive GP Inc., an innovator in immersive sim racing experiences; today announced a strategic partnership to support Grand Prix™ Season Singapore 2025 (GPSS 2025) through acti ...

Revolutionary platform aims to make life-saving overdose reversal therapies more affordable, accessible, and effective worldwideVANCOUVER, British Columbia, Sept. 30, 2025 (GLOBE NEWSWIRE) -- via IBN -- Branded Legacy, Inc. (OTC: BLEG), a dynamic holding company focused on innovative life sciences and wellness solutions, is thrilled to announce that its subsidiary, BioLegacy Evaluative Group Inc. ("BioLegacy"), has filed a provisional patent application with the United States Patent and Trademark Office (US ...

Doug Caccese steps into strategic advisor role before leaving Verisk in January 2026 Saurabh Khemka President of Underwriting Solutions JERSEY CITY, N.J., Sept. 30, 2025 (GLOBE NEWSWIRE) -- Verisk (Nasdaq: VRSK), a leading strategic data analytics and technology partner to the global insurance industry, today announced that Saurabh Khemka has been named president of Underwriting Solutions, effective immediately. “Saurabh has been a great partner to our underwriting clients and has repeatedly used their n ...

New Agreement with Thermo Fisher Scientific Expands Domestic Capacity to Support Future Commercial Manufacturing of Vaxcyte’s Broad-Spectrum Pneumococcal Conjugate Vaccine Candidates SAN CARLOS, Calif., Sept. 30, 2025 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company, today announced a new agreement with Thermo Fisher Scientific Inc., the world leader in serving science, to bring additional fill-finish commercial manufacturing for Vaxcyte’s broad-spectrum pneumoco ...